Republicans in Congress are pushing to make DTC cash drug purchases more attractive by requiring insurers to count that spending toward deductibles and out-of-pocket limits, Axios reports

The change would address a key drawback for insured patients, whose cash payments currently do not help them reach the point where insurance covers more of their healthcare costs, Axios says